These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7671929)

  • 1. Medical treatment of infective endocarditis: general principles.
    Besnier JM; Choutet P
    Eur Heart J; 1995 Apr; 16 Suppl B():72-4. PubMed ID: 7671929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental endocarditis: a review of its relevance to human endocarditis.
    Carbon C
    J Antimicrob Chemother; 1993 May; 31 Suppl D():71-85. PubMed ID: 8335526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacterial endocarditis: microbiological diagnosis].
    Rotter M
    Acta Med Austriaca; 1993; 20(4):105-7. PubMed ID: 8237279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the antibiotic dosage schedule on efficacy in experimental endocarditis.
    Carbon C
    Scand J Infect Dis Suppl; 1990; 74():163-72. PubMed ID: 2097705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R
    Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of using relapse studies or tests for detection of antibiotic resistance before considering that a treatment for multidrug-resistant enterococcal experimental endocarditis is effective.
    Caron F
    J Infect Dis; 1997 Jan; 175(1):232-3. PubMed ID: 8985229
    [No Abstract]   [Full Text] [Related]  

  • 11. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefamandole-aminoglycoside therapy of experimental enterococcal endocarditis.
    Weinstein AJ; Fieker D; Hall G
    J Antimicrob Chemother; 1983 Jan; 11(1):61-7. PubMed ID: 6826487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Enterococcus endocarditis model in experimental animals and its relevance to human infection.
    Gutschik E
    J Antimicrob Chemother; 1993 May; 31 Suppl D():87-95. PubMed ID: 8335527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
    Werth BJ; Shireman LM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic therapy of infectious endocarditis (when, with what drug, how long?].
    Schuler G
    Z Kardiol; 1994 Jan; 83(1):2-8. PubMed ID: 8147065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infective endocarditis--a review of 21 cases in last 10 years].
    Okada K; Uchida Y; Sawae Y
    Fukuoka Igaku Zasshi; 1998 Feb; 89(2):34-43. PubMed ID: 9549176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment of streptococcal and enterococcal endocarditis: an overview.
    Francioli P
    Eur Heart J; 1995 Apr; 16 Suppl B():75-9. PubMed ID: 7671930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of antimicrobial therapy in surgery.
    DiPiro JT; Edmiston CE; Bohnen JM
    Am J Surg; 1996 Jun; 171(6):615-22. PubMed ID: 8678212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infectious endocarditis caused by a glycopeptide-resistant enterococus].
    Jouaihia W; Ghozzi R; Kamoun A; Baccar H; Bousnina A; Ben Redjeb S
    Tunis Med; 2000 Nov; 78(11):667-70. PubMed ID: 11155391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.